Clinical Trial Update: Pembrolizumab, Olaparib, and Temozolomide for People With Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pembrolizumab, olaparib, and temozolomide in glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Lynparza (olaparib)
• Temodar (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioma | Phase 2 | Status: RECRUITING